Time to diagnosis and breast cancer stage by race/ethnicity.
Breast Cancer Res. Treat., Dec;136(3):813-21 (2012)
Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines.
J Natl Compr Canc Netw., Jul;10(7):821-9 (2012)
NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer.
PLoS ONE., 7(6):e38783 (2012)
Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.
Cancer., Dec;118(24):6022-30 (2012)
Clustering of place of birth for women with breast cancer: differences by tumor characteristics.
Cancer Causes Control., May (2012)
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.
J. Clin. Oncol., Jun;30(18):2218-26 (2012)
The effect of age on delay in diagnosis and stage of breast cancer.
Oncologist., 17(6):775-82 (2012)
Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.
Cancer., Nov;118(22):5463-72 (2012)
True patriotism: a generation of commitment to quality in the Veterans Health Administration.
J. Clin. Oncol., Apr;30(10):1027-9 (2012)
Breast education in general surgery residency.
Am Surg., Jan;78(1):42-5 (2012)
Exploring the first days of adjustment to cancer: a modification of acclimating to breast cancer theory.
Cancer Nurs., 35(1):3-18 (2012 Jan-Feb)
Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics.
J. Nutr., Jan;142(1):91-8 (2012)
Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis.
Cancer Epidemiol. Biomarkers Prev., Jan;21(1):239-42 (2012)
Promoter methylation of E-cadherin, p16, and RAR-Î²(2) genes in breast tumors and dietary intake of nutrients important in one-carbon metabolism.
Nutr Cancer., 63(7):1143-50 (2011)
Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study.
Am. J. Clin. Nutr., Sep;94(3):831-8 (2011)
Institutional variation in the surgical treatment of breast cancer: a study of the NCCN.
Ann. Surg., Aug;254(2):339-45 (2011)
Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk.
BMC Cancer., 11:278 (2011)
Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study.
Carcinogenesis., Aug;32(8):1223-30 (2011)
Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.
Cancer Causes Control., Jul;22(7):965-75 (2011)
Continued use of trastuzumab beyond disease progression in the national comprehensive cancer network: should we practice ahead of the evidence?
Oncologist., 16(5):559-65 (2011)
Impact of body mass index on clinical outcomes in triple-negative breast cancer.
Cancer., Sep;117(18):4132-40 (2011)
Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study.
PLoS ONE., 6(2):e17251 (2011)
Challenges and implementation of a women's breast health initiative in rural Kashmir.
Breast., Apr;20 Suppl 2:S46-50 (2011)
Race and ethnicity are associated with delays in breast cancer treatment (2003-2006).
J Health Care Poor Underserved., Feb;22(1):128-41 (2011)
Is there a need for axillary dissection in breast cancer?
J Natl Compr Canc Netw., Feb;9(2):225-30 (2011)
Invasive breast cancer.
J Natl Compr Canc Netw., Feb;9(2):136-222 (2011)
Quality measurement in cancer care delivery.
Ann. Surg. Oncol., Mar;18(3):611-8 (2011)
The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort.
Breast Cancer Res. Treat., Apr;126(3):797-802 (2011)
Alcohol consumption in relation to aberrant DNA methylation in breast tumors.
Alcohol., Nov;45(7):689-99 (2011)
Breast cancer racial disparities: unanswered questions.
Cancer Res., Feb;71(3):640-4 (2011)
The anticipated and unintended consequences of the patient protection and affordable care act on cancer research.
Cancer J., 16(6):606-13 (2010 Nov-Dec)
Breast cancer: noninvasive and special situations.
J Natl Compr Canc Netw., Oct;8(10):1182-207 (2010)
Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification.
Cancer., Dec;116(24):5592-8 (2010)
Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006.
J. Clin. Oncol., Sep;28(27):4135-41 (2010)
Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.
Breast Cancer Res. Treat., Feb;126(1):157-65 (2011)
Commentary: "help the doctor"-the culture shift to 21st century care management.
J Oncol Pract., Mar;6(2):89-90 (2010)
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.
J. Clin. Oncol., Jul;28(19):3146-53 (2010)
Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study.
Cancer Causes Control., Sep;21(9):1503-12 (2010)
Claims data linked to hospital registry data enhance evaluation of the quality of care of breast cancer.
J Surg Oncol., Jun;101(7):593-9 (2010)
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.
Ann. Surg. Oncol., Jun;17(6):1471-4 (2010)
The impact of breast reconstruction on the delivery of chemotherapy.
Cancer., Apr;116(7):1791-800 (2010)
Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.
Breast Cancer Res. Treat., Jul;122(1):229-35 (2010)
NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry.
J Natl Compr Canc Netw., Sep;7 Suppl 6:S1-S21; quiz S22-3 (2009)
Alcohol consumption and breast tumor mitochondrial DNA mutations.
Breast Cancer Res. Treat., Jun;121(2):453-60 (2010)
Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005.
Cancer., Dec;115(23):5404-12 (2009)
Nipple-sparing mastectomy: how often is the nipple involved?
J. Clin. Oncol., Oct;27(30):4930-2 (2009)
Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer risk.
Cancer Epidemiol. Biomarkers Prev., Sep;18(9):2453-9 (2009)
ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast.
Int. J. Radiat. Oncol. Biol. Phys., Mar;73(4):997-1002 (2009)
DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR.
Cancer Epidemiol. Biomarkers Prev., Mar;18(3):998-1002 (2009)
Indications for breast MRI in the patient with newly diagnosed breast cancer.
J Natl Compr Canc Netw., Feb;7(2):193-201 (2009)
Breast cancer. Clinical practice guidelines in oncology.
J Natl Compr Canc Netw., Feb;7(2):122-92 (2009)
Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancer.
J Natl Compr Canc Netw., Feb;7(2):115-21 (2009)
Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data.
Cancer., Feb;115(4):716-24 (2009)
Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer.
J. Clin. Oncol., Dec;26(34):5553-60 (2008)
Selecting high priority quality measures for breast cancer quality improvement.
Med Care., Aug;46(8):762-70 (2008)
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures.
J. Clin. Oncol., Jul;26(21):3631-7 (2008)
American College of Radiology appropriateness criteria on conservative surgery and radiation: stages I and II breast carcinoma.
J Am Coll Radiol., Jun;5(6):701-13 (2008)
Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
Cancer Epidemiol. Biomarkers Prev., May;17(5):1082-7 (2008)
Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network.
Int. J. Radiat. Oncol. Biol. Phys., Dec;72(5):1434-40 (2008)
Getting to better cancer care: results of a society of surgical oncology survey.
Ann. Surg. Oncol., Sep;15(9):2363-71 (2008)
DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.
Breast Cancer Res. Treat., Apr;114(3):559-68 (2009)
Early adoption and disturbing disparities in sentinel node biopsy in breast cancer.
J. Natl. Cancer Inst., Apr;100(7):449-50 (2008)
Lymph node examination rate, survival rate, and quality of care in colon cancer.
JAMA., Feb;299(8):896; author reply 897-8 (2008)
Lymph node examination rate, survival rate, and quality of care in colon cancer.
JAMA., Feb;299(8):896-7; author reply 897-8 (2008)
Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis.
Oncology., 71(5-6):456-9 (2006)
Dietary patterns related to glycemic index and load and risk of premenopausal and postmenopausal breast cancer in the Western New York Exposure and Breast Cancer Study.
Am. J. Clin. Nutr., Aug;86(2):465-71 (2007)
Exposure to traffic emissions throughout life and risk of breast cancer: the Western New York Exposures and Breast Cancer (WEB) study.
Cancer Causes Control., Nov;18(9):947-55 (2007)
Linked claims and medical records for cancer case management : evaluation of mammography abnormalities.
Cancer., Aug;110(3):518-24 (2007)
Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
J. Clin. Oncol., Aug;25(22):3251-8 (2007)
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer.
J Natl Compr Canc Netw., May;5 Suppl 1:S1-22; quiz S23-2 (2007)
Evidence and controversies in the use of post-mastectomy radiation.
J Natl Compr Canc Netw., Mar;5(3):331-8 (2007)
Invasive breast cancer.
J Natl Compr Canc Netw., Mar;5(3):246-312 (2007)
Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status.
Breast Cancer Res. Treat., Oct;99(3):309-11 (2006)
BI-RADS classification for management of abnormal mammograms.
J Am Board Fam Med., 19(2):161-4 (2006 Mar-Apr)
Sentinel lymph node in breast cancer.
Curr. Opin. Obstet. Gynecol., Feb;18(1):53-8 (2006)
A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network.
Ann. Surg., Feb;243(2):241-9 (2006)
Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
J Surg Oncol., Feb;93(2):129-32 (2006)
The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers.
J. Clin. Oncol., Jan;24(3):361-9 (2006)
Genomic instability in invasive breast carcinoma measured by inter-Simple Sequence Repeat PCR.
Breast Cancer Res. Treat., May;97(1):107-10 (2006)
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
J. Clin. Oncol., Oct;23(30):7703-20 (2005)
Secondhand smoke exposure in early life and the risk of breast cancer among never smokers (United States).
Cancer Causes Control., Aug;16(6):683-9 (2005)
J Natl Compr Canc Netw., May;3(3):238-89 (2005)
Re: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.
J. Natl. Cancer Inst., Mar;97(6):463-4; author reply 464-5 (2005)
Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure.
Cancer Epidemiol. Biomarkers Prev., Jan;14(1):53-60 (2005)
Geographic clustering of residence in early life and subsequent risk of breast cancer (United States).
Cancer Causes Control., Nov;15(9):921-9 (2004)
Dietary intake of conjugated linoleic acids and risk of premenopausal and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study).
Cancer Epidemiol. Biomarkers Prev., Sep;13(9):1480-4 (2004)
Dietary lignan intakes and risk of pre- and postmenopausal breast cancer.
Int. J. Cancer., Sep;111(3):440-3 (2004)
Lymphedema secondary to postmastectomy radiation: incidence and risk factors.
Ann. Surg. Oncol., Jun;11(6):573-80 (2004)
The effectiveness of complete decongestive physiotherapy for the treatment of lymphedema following groin dissection for melanoma.
J Surg Oncol., Mar;85(4):187-92 (2004)
Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.
AJR Am J Roentgenol., Dec;181(6):1679-84 (2003)
Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers.
J. Natl. Cancer Inst., Oct;95(20):1514-21 (2003)
The role of the surgeon in quality cancer care.
Curr Probl Surg., Sep;40(9):511-90 (2003)
Mammographic and clinical predictors of drainage patterns in breast lymphoscintigrams obtained during sentinel node procedures.
Clin Nucl Med., Jul;28(7):558-64 (2003)
Effect of stereotactic core needle biopsy on pathologic measurement of tumor size of T1 invasive breast carcinomas presenting as mammographic masses.
Cancer., May;97(9):2137-41 (2003)
Counterpoint: sentinel lymph node biopsy is not indicated for ductal carcinoma in situ.
J Natl Compr Canc Netw., Apr;1(2):207-12 (2003)
Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of care.
J. Clin. Oncol., Mar;21(5):855-63 (2003)